HIV vaccination research

Major national science and technology projects -- special projects for the prevention and treatment of major infectious diseases, including AIDS and viral hepatitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024654

Enrollment

Unknown

Registered

2019-07-20

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

Experimental group:Vaccination plan immunization

control group:no

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Aged 15% for anti-viral therapy for more than 3 months).

Exclusion criteria

Exclusion criteria: Children with protective antibody already.

Design outcomes

Primary

Measure	Time frame
IgG, IgM;CD4 T-cell;blood routine;Blood chemistry;	—

Countries

China

Contacts

Public ContactZhang Fujie

Beijing Ditan Hospital affiliated to Capital Medical University

treatment@chinaaids.cn+86 13001953958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026